AFAP1-AS1通过miR-103a-3p激活PI3K/AKT通路促进垂体腺瘤细胞增殖
本研究在大鼠垂体腺瘤细胞中探讨AFAP1-AS1作为miR-103a-3p竞争性内源RNA调控PI3K/AKT通路的机制。荧光素酶报告基因实验证实AFAP1-AS1与rno-miR-103a-3p结合;miR-103a-3p过表达抑制细胞增殖、诱导凋亡、阻滞细胞周期于G/S期、减少GH和PRL分泌并抑制PI3K/AKT通路。结论提示AFAP1-AS1和miR-103a-3p可能成为垂体腺瘤的潜在治疗靶点。
要点
- AFAP1-AS1在大鼠垂体腺瘤细胞中与rno-miR-103a-3p结合。
- miR-103a-3p过表达抑制垂体腺瘤细胞增殖并诱导凋亡。
- AFAP1-AS1/miR-103a-3p轴通过PI3K/AKT通路调控垂体腺瘤生长。
核心结论
- AFAP1-AS1和miR-103a-3p可能成为垂体腺瘤的潜在治疗靶点。
研究设计与样本
- 研究采用大鼠垂体腺瘤细胞(GH3和MMQ细胞),通过荧光素酶报告基因实验检测AFAP1-AS1与rno-miR-103a-3p的结合。
- 采用qRT-PCR检测rno-miR-103a-3p表达,CCK-8和流式细胞术检测增殖、细胞周期和凋亡。
- 采用ELISA检测GH3和MMQ细胞培养上清中大鼠生长激素(GH)和催乳素(PRL)水平。
主要发现
- AFAP1-AS1在大鼠垂体腺瘤细胞中与rno-miR-103a-3p结合。
- rno-miR-103a-3p过表达抑制大鼠垂体腺瘤细胞增殖、诱导细胞凋亡、阻滞细胞周期于G/S期、减少GH和PRL分泌并抑制PI3K/AKT信号通路。
- 激活PI3K/AKT信号通路可逆转rno-miR-103a-3p过表达对增殖及GH和PRL分泌的影响。
- 同时共表达si-AFAP1-AS1和rno-miR-103a-3p抑制剂可促进细胞增殖和细胞周期进展、减少细胞凋亡、增强GH和PRL分泌并激活PI3K/AKT信号通路。
临床怎么用
- 本研究为细胞水平机制探索,提示AFAP1-AS1/miR-103a-3p轴及PI3K/AKT通路可能作为垂体腺瘤的干预靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: We previously found that AFAP1-AS1 regulates the cell growth of pituitary tumor cells; however, the mechanism still remains unclear. Here, we investigated whether AFAP1-AS1 acts as a competing endogenous RNA of miR-103a-3p to regulate pituitary adenoma growth via the PI3K/AKT pathway. METHODS: The bind between AFAP1-AS1 and rno-miR-103a-3p was measured by luciferase reporter assay, and rno-miR-103a-3p expression was measured by quantitative reverse transcription polymerase chain reaction. Proliferation, cell cycle, and apoptosis were measured by cell counting kit 8 and flow cytometry. Rat growth hormone (GH) and prolactin (PRL) levels in culture supernatant of GH3 and MMQ cells were measured by enzyme-linked immunosorbent assay. RESULTS: AFAP1-AS1 binds to rno-miR-103a-3p in rat pituitary adenoma cells. Additionally, rno-miR-103a-3p overexpression suppressed rat pituitary adenoma cell proliferation, induced cell apoptosis, arrested cell cycle in the G/S phase, reduced GH and PLR secretion, and inhibited the PI3K/AKT signaling pathway. Activated PI3K/AKT signaling pathway revised the effect of rno-miR-103a-3p overexpression on proliferation and GH and PLR secretion. Coexpression of both si-AFAP1-AS1 and rno-miR-103a-3p inhibitor promoted cell proliferation and cell cycle progression, reduced cell apoptosis, enhanced GH and PLR secretion, and activated the PI3K/AKT signaling pathway in rat pituitary adenoma cells. CONCLUSION: We found that AFAP1-AS1 and miR-103a-3p could be a potential therapeutic target for pituitary adenoma.
引用
- Tang H, Zhu D, Zhang G, et al. AFAP1-AS1 Promotes Proliferation of Pituitary Adenoma Cells through miR-103a-3p to Activate PI3K/AKT Signaling Pathway. World Neurosurg. 2019. PMID: 31299308. doi:10.1016/j.wneu.2019.07.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。